Literature DB >> 32647346

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.

Antoni G Wrobel1, Donald J Benton2, Pengqi Xu3,4, Chloë Roustan5, Stephen R Martin5, Peter B Rosenthal6, John J Skehel3, Steven J Gamblin7.   

Abstract

SARS-CoV-2 is thought to have emerged from bats, possibly via a secondary host. Here, we investigate the relationship of spike (S) glycoprotein from SARS-CoV-2 with the S protein of a closely related bat virus, RaTG13. We determined cryo-EM structures for RaTG13 S and for both furin-cleaved and uncleaved SARS-CoV-2 S; we compared these with recently reported structures for uncleaved SARS-CoV-2 S. We also biochemically characterized their relative stabilities and affinities for the SARS-CoV-2 receptor ACE2. Although the overall structures of human and bat virus S proteins are similar, there are key differences in their properties, including a more stable precleavage form of human S and about 1,000-fold tighter binding of SARS-CoV-2 to human receptor. These observations suggest that cleavage at the furin-cleavage site decreases the overall stability of SARS-CoV-2 S and facilitates the adoption of the open conformation that is required for S to bind to the ACE2 receptor.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32647346      PMCID: PMC7610980          DOI: 10.1038/s41594-020-0468-7

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  1 in total

1.  Novel SARS-like betacoronaviruses in bats, China, 2011.

Authors:  Li Yang; Zhiqiang Wu; Xianwen Ren; Fan Yang; Guimei He; Junpeng Zhang; Jie Dong; Lilian Sun; Yafang Zhu; Jiang Du; Shuyi Zhang; Qi Jin
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

  1 in total
  185 in total

1.  Modeling in the Time of COVID-19: Statistical and Rule-based Mesoscale Models.

Authors:  Ngan Nguyen; Ondrej Strnad; Tobias Klein; Deng Luo; Ruwayda Alharbi; Peter Wonka; Martina Maritan; Peter Mindek; Ludovic Autin; David S Goodsell; Ivan Viola
Journal:  IEEE Trans Vis Comput Graph       Date:  2021-01-28       Impact factor: 4.579

Review 2.  Post-acute COVID-19 syndrome.

Authors:  Ani Nalbandian; Kartik Sehgal; Aakriti Gupta; Mahesh V Madhavan; Claire McGroder; Jacob S Stevens; Joshua R Cook; Anna S Nordvig; Daniel Shalev; Tejasav S Sehrawat; Neha Ahluwalia; Behnood Bikdeli; Donald Dietz; Caroline Der-Nigoghossian; Nadia Liyanage-Don; Gregg F Rosner; Elana J Bernstein; Sumit Mohan; Akinpelumi A Beckley; David S Seres; Toni K Choueiri; Nir Uriel; John C Ausiello; Domenico Accili; Daniel E Freedberg; Matthew Baldwin; Allan Schwartz; Daniel Brodie; Christine Kim Garcia; Mitchell S V Elkind; Jean M Connors; John P Bilezikian; Donald W Landry; Elaine Y Wan
Journal:  Nat Med       Date:  2021-03-22       Impact factor: 53.440

3.  SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.

Authors:  Annachiara Rosa; Valerie E Pye; Carl Graham; Luke Muir; Jeffrey Seow; Kevin W Ng; Nicola J Cook; Chloe Rees-Spear; Eleanor Parker; Mariana Silva Dos Santos; Carolina Rosadas; Alberto Susana; Hefin Rhys; Andrea Nans; Laura Masino; Chloe Roustan; Evangelos Christodoulou; Rachel Ulferts; Antoni G Wrobel; Charlotte-Eve Short; Michael Fertleman; Rogier W Sanders; Judith Heaney; Moira Spyer; Svend Kjær; Andy Riddell; Michael H Malim; Rupert Beale; James I MacRae; Graham P Taylor; Eleni Nastouli; Marit J van Gils; Peter B Rosenthal; Massimo Pizzato; Myra O McClure; Richard S Tedder; George Kassiotis; Laura E McCoy; Katie J Doores; Peter Cherepanov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

4.  The PRRA insert at the S1/S2 site modulates cellular tropism of SARS-CoV-2 and ACE2 usage by the closely related Bat RaTG13.

Authors:  Shufeng Liu; Prabhuanand Selvaraj; Christopher Z Lien; Ivette A Nunez; Wells W Wu; Chao-Kai Chou; Tony T Wang
Journal:  J Virol       Date:  2021-03-08       Impact factor: 6.549

Review 5.  Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms.

Authors:  Yoshitaka Kase; Hideyuki Okano
Journal:  Inflamm Regen       Date:  2021-05-07

6.  Profiling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics.

Authors:  Mengjia Wu; Yi Zhang; Mark Grosser; Steven Tipper; Deon Venter; Hua Lin; Jie Lu
Journal:  Front Res Metr Anal       Date:  2021-05-24

7.  Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein.

Authors:  Pui Wang; Siu-Ying Lau; Shaofeng Deng; Pin Chen; Bobo Wing-Yee Mok; Anna Jinxia Zhang; Andrew Chak-Yiu Lee; Kwok-Hung Chan; Rachel Chun-Yee Tam; Haoran Xu; Runhong Zhou; Wenjun Song; Li Liu; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Zhiwei Chen; Kwok-Yung Yuen; Honglin Chen
Journal:  Nat Commun       Date:  2021-05-13       Impact factor: 14.919

Review 8.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

Review 9.  COVID-19, hydroxychloroquine and the importance of disease progression.

Authors:  John A Budny
Journal:  Toxicol Res (Camb)       Date:  2021-03-09       Impact factor: 3.524

10.  The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.

Authors:  Helena Winstone; Maria Jose Lista; Alisha C Reid; Clement Bouton; Suzanne Pickering; Rui Pedro Galao; Claire Kerridge; Katie J Doores; Chad M Swanson; Stuart J D Neil
Journal:  J Virol       Date:  2021-04-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.